HOUSE 2466116th CongressReceived in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

State Opioid Response Grant Authorization Act of 2020

Last Action: 11/18/2020

Actions

2020-11-18Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
2020-11-17Motion to reconsider laid on the table Agreed to without objection.
2020-11-17On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5809-5810)
2020-11-17Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5809-5810)
2020-11-17DEBATE - The House proceeded with forty minutes of debate on H.R. 2466.
2020-11-17Considered under suspension of the rules. (consideration: CR H5809-5811)
2020-11-17Mr. Pallone moved to suspend the rules and pass the bill, as amended.
2020-11-12Placed on the Union Calendar, Calendar No. 466.
2020-11-12Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-568.
2020-11-12Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-568.
2020-09-09Ordered to be Reported by Voice Vote.
2020-09-09Committee Consideration and Mark-up Session Held.
2019-05-02Referred to the Subcommittee on Health.
2019-05-01Referred to the House Committee on Energy and Commerce.
2019-05-01Introduced in House

Showing 15 of 16 actions. Full history on Congress.gov.

CRS Summary

As of 2020-11-17 (53)

State Opioid Response Grant Authorization Act of 2020

This bill reauthorizes through FY2026 and expands the scope of the State Opioid Response Grant program that is administered by the Substance Abuse and Mental Health Services Administration. Current law limits the use of these grants to specifically address the opioid crisis and opioid use disorders, while this bill allows the grants to address substance use disorders more broadly.

Cosponsors (20)

Kelly Armstrong (R-ND)
Mikie Sherrill (D-NJ)
Denver Riggleman (R-VA)
Anthony Brown (D-MD)
Tim Burchett (R-TN)
WM. CLAY (D-MO)
Madeleine Dean (D-PA)
Sylvia Garcia (D-TX)
Pramila Jayapal (D-WA)
Ann Kuster (D-NH)
Susie Lee (D-NV)
JOHN LEWIS (D-GA)
Lucy McBath (D-GA)
DAVID PRICE (D-NC)
Harley Rouda (D-CA)
Marc Veasey (D-TX)
Cynthia Axne (D-IA)
Angie Craig (D-MN)
Bill Foster (D-IL)
Jim Hagedorn (R-MN)

Subjects

Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Health care coverage and access
Health care quality
Health programs administration and funding
Health promotion and preventive care
Prescription drugs
State and local government operations

Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.